0.25% acetic acid (AA). The sensitivity of TNS inhibition to cumulative intravenous doses of selective OR antagonists (cyprodime for µ, nor-binaltorphimine for κ, or naltrindole for δ ORs) was tested. Results: Naloxone (1 mg/kg, i.v., an antagonist for µ, κ, and δ ORs) was administered at the end of each experiment. AA caused bladder overactivity and significantly (P<0.01) reduced bladder capacity to 21.1±2.6% of the saline control. TNS at 2 or 4 times threshold (T) intensity for inducing toe movement significantly (P<0.01) restored bladder capacity to 52.9±3.6% or 57.4±4.6% of control, respectively. Cyprodime (0.3-1.0 mg/kg) completely removed TNS inhibition without changing AA control capacity. Nor-binaltorphimine (3-10 mg/kg) also completely reversed TNS inhibition and significantly (P<0.05) increased AA control capacity. Naltrindole(1-10 mg/kg) reduced (P<0.05) TNS inhibition but significantly (P<0.05) increased AA control capacity. Naloxone (1 mg/kg) had no effect in cyprodime pre-treated cats, but reversed the nor-binaltorphimine induced increase in bladder capacity and eliminated the TNS inhibition remaining in naltrindole pre-treated cats. Conclusions: These results indicate a major role of µ and κ ORs in TNS inhibition while δORs play a minor role. Meanwhile, κ and δORs also have an excitatory role in irritation-induced bladder overactivity. 
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Background: Oxidative stress is a causal factor and key promoter of urolithiasis associated with renal tubular epithelium cell injury. The present study was designed to investigate the preventive effects of metformin on renal tubular cell injury induced by oxalate and stone formation in a hyperoxaluric rat model. Methods: MTT assays were carried out to determine the protection of metformin in MDCK cells from oxalateinduced cytotoxicity. The intracellular superoxide dismutase (SOD) activities and malondialdehyde (MDA) levels were measured to investigate the antioxidant effect of metformin. We divided male Sprague-Dawley rats into a control group, a 0.75% ethylene glycol (EG) group and a 0.75% ethylene glycol plus 200 mg/kg/day metformin group. Blood and 24-hour urine samples, and kidney sections were collected at the end of 8-week treatment. Oxidative stress was evaluated with SOD activities and MDA levels in renal tissues. Crystal formations were examined using hematoxylin and eosin (HE) staining and polarized light optical microscopy. Results: Co-exposure to metformin significantly inhibited the decrease of the viability in MDCK cells induced by oxalate. Besides, metformin markly prevented the increased concentration of MDA and the decreased tendency of SOD in oxalate-induced MDCK cells. In vivo, the increased MDA levels and the reduction of SOD activity were detected in EG-induced group compared with controls, while these parameters reversed significantly in the rats co-treated with EG and metformin. Kidney crystal formation in EG plus metformin group was decreased significantly compared with that in EG group. Conclusions: Metformin suppressed urinary crystal deposit formation through renal tubular cell protection and antioxidative effects. 
